
Predicta Med

Categories
Artificial Intelligence, Decision Support Systems, Precision / Personalized Medicine
Therapeutic Areas
Autoimmune Diseases, Internal Medicine, Primary Care
Company Status
R&D
An AI based decision support platform for early detection of immune-related diseases
Predicta Med's platform aims to improve the quality of care for patients with immune-related conditions and reduce healthcare costs by enabling providers to detect these diseases months to years earlier than the current standard of care. The platform facilitates identification of individuals with undiagnosed immune-related conditions, enabling targeted interventions earlier in disease course to help prevent disease deterioration and complications. To date, the models were trained and validated on more than 6.5M electronical patients records and 1.7M claims records.
